Virginia Smit
Promovendus
- Naam
- V. Smit MSc
- Telefoon
- +31 71 527 2727
- v.smit@lacdr.leidenuniv.nl
Promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Biopharmaceutics
- Hemme E.: Biskop D., Depuydt M.A.C., Smit V., Delfos L., Bernabé Kleijn M.N.A., Foks A.C., Kuiper J. & Bot I. (2023), Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr-/- mice, Vascular Pharmacology 150: 107172.
- Smit V., Mol J. de, Schaftenaar F.H., Depuydt M.A.C., Postel R.J., Smeets D.: Verheijen F.W.M., Bogers L., Duijn J. van, Verwilligen R.A.F., Grievink H.W., Bernabé Kleijn M.N.A., Ingen E. van, Jong M.J.M. de, Goncalves L.: Peeters J.A.H.M., Smeets H.J., Wezel A., Polansky J.K., Winther M.P.J. de, Binder C.J., Tsiantoulas D., Bot I., Kuiper J. & Foks A.C. (2023), Single-cell profiling reveals age-associated immunity in atherosclerosis, Cardiovascular Research 119(15): 2508-2521.
- Douna H., Smit V., Puijvelde G.H.M. van, Kiss M.G., Binder C.J., Bot I., Kuchroo V.K., Lichtman A.H., Kuiper J. & Foks A.C. (2022), Tim-1 mucin domain-mutant mice display exacerbated atherosclerosis, Atherosclerosis 352: 1-9.
- Grievink H.W., Smit V., Huisman B.W., Gal P., Yavuz Y., Klerks C., Binder C.J., Bot I., Kuiper J., Foks A.C. & Moerland M. (2022), Cardiovascular risk factors: the effects of ageing and smoking on the immune system, an observational clinical study, Frontiers in immunology 13: 968815.
- Depuydt M.A.C., Smit V., Lozano Vigario F., Bernabé Kleijn M.N.A., Vries M.R. de, Quax P.H.A., Wezel A., Smeets H.J., Kuiper J., Foks A.C., Bot I. & Slütter B.A. (2022), Granzyme B+CD4+T cells associate with an unstable plaque phenotype in advanced human atherosclerosis, Cardiovascular Research 118(Supplement_1): cvac066.229.
- Grievink H.W., Smit V., Verwilligen R.A.F., Bernabé Kleijn M.N.A., Smeets D., Binder C.J., Yagita H., Moerland M., Kuiper J., Bot I. & Foks A.C. (2021), Stimulation of the PD-1 pathway decreases atherosclerotic lesion development in Ldlr deficient mice, Frontiers in Cardiovascular Medicine 8: 740531.
- Grievink H.W., Smit V., Verwilligen R.A.F., Bernabé Kleijn M.N.A., Smeets D., Binder C.J., Yagita H., Moerland M., Kuiper J., Bot I. & Foks A.C. (2021), Stimulation of the PD-1 pathway decreases atherosclerotic lesion development in Ldlr deficient mice, Frontiers in Cardiovascular Medicine 8: 740531.